-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
ArriVent BioPharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2023 to Q3 2025.
- ArriVent BioPharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 41.9M shares, a 24.8% increase year-over-year.
- ArriVent BioPharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 31.5M shares, a 1370% increase from 2023.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)